Alignment Healthcare LLC Stock Analysis
| ALHC Stock | USD 16.99 -0.13 -0.76% |
200 Day MA 17.2327 | 50 Day MA 20.7863 | Beta 1.189 |
Macro event markers
Alignment Healthcare LLC appears undervalued based on a Real Value estimate of $19.89 and a Target Price of $25.5. The core goal of stock analysis is to estimate intrinsic value. The estimate provides a valuation baseline beyond day-to-day price moves. The two primary approaches to stock analysis are fundamental and technical analysis. This pairing links intrinsic-value inputs with observed market behavior.
Alignment Healthcare LLC holds a debt-to-equity ratio of 0.606. The current value of Debt To Assets are estimated at 0.43, reflecting a climbing pattern. Previously, Debt To Assets were valued at 0.32. As of today, Analyst projections suggest Long Term Debt To Capitalization may climb to 0.91, whereas Short and Long Term Debt Total is moving lower toward about 228.3 M. Alignment Healthcare's financial risk can rise as debt increases relative to equity. Debt service costs can influence earnings and cash flow coverage. Asset vs Debt
Equity vs Debt
Price Book 20.5234 | Enterprise Value Ebitda 75.1228 | Price Sales 0.9318 | Shares Float 169.4 M | Wall Street Target Price 25.5 |
Alignment Healthcare LLC (ALHC) recorded an increase of $109.1 million in Net Income, a net loss of $724 thousand, and a net loss attributable to common shareholders of $141.3 million.
Detailed breakdowns are available in Interest Expense and Depreciation And Amortization.
Alignment | Build AI portfolio with Alignment Stock |
Stock Analysis Notes
About 96.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.39. Alignment Healthcare LLC had not issued any dividends in recent years. Alignment Healthcare LLC (ALHC) recorded $0.03 in Intangibles To Total Assets, $1.1 billion in Total Assets, and a Return On Assets of -0.1%.Total Assets | 665.73 Million |
Investor Insights and Alerts
Automated alerts tied to Alignment Healthcare LLC help investors surface material conditions that may support or challenge the current thesis before they become expensive mistakes. In practice, the value comes from seeing which signals are new, which are persistent, and which are strong enough to justify action.
| Alignment Healthcare generated a negative expected return over the last 90 days | |
| The company reported previous year's revenue of 3.95 B. Net Loss for the year was -724 K with profit before overhead, payroll, taxes, and interest of 488.56 M. | |
| Alignment Healthcare has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Alignment Healthcare Conference CEO Kao touts scalable care model, 31 percent growth, improving MLR |
Largest EPS Surprises
For Alignment Healthcare, consensus-versus-actual EPS differences are a core event driver. Forecasts are usually built from management commentary plus analyst model scenarios. For this stock, read EPS surprises with profitability quality and forward revisions.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-25 | 2024-12-31 | -0.084 | -0.057 | 0.027 | 32 | ||
2024-05-02 | 2024-03-31 | -0.22 | -0.25 | -0.03 | 13 | ||
2024-02-27 | 2023-12-31 | -0.22 | -0.25 | -0.03 | 13 |
Environmental, Social, and Governance (ESG) Scores
ESG analysis for Alignment Healthcare LLC is not only about values-based screening; it can also highlight operating practices and governance choices with real financial consequences. These scores become more relevant when they are compared against peers facing similar regulatory, labor, and supply-chain pressures.
Top Institutional Investors Holding Alignment Stock
Institutional ownership matters in Alignment Healthcare LLC because pension funds, mutual funds, banks, and advisers can materially influence liquidity, governance, and price discovery. Used correctly, institutional data helps investors understand who may be setting the marginal price and how resilient that holder base could be under stress.
| Shares | Ing Investment Management Llc | 2025-12-31 | 3.7 M | Geode Capital Management, Llc | 2025-09-30 | 3.5 M | State Street Corp | 2025-09-30 | 3.2 M | Point72 Asset Management, L.p. | 2025-09-30 | 2.8 M | Renaissance Technologies Corp | 2025-12-31 | 2.7 M | Broad Bay Capital Management, Lp | 2025-12-31 | 2.5 M | Next Century Growth Investors Llc | 2025-12-31 | 2.3 M | William Blair Investment Management, Llc | 2025-12-31 | 2.3 M | Loomis, Sayles & Company Lp | 2025-12-31 | 2.2 M | Vanguard Group Inc | 2025-12-31 | 15.5 M | Fmr Inc | 2025-12-31 | 14.7 M |
Market Capitalization
Current market cap data values Alignment Healthcare LLC at 3.68 B, which keeps the company in the mid-cap bracket across health care providers & services. Supporting market cap data includes about 204.3 M shares outstanding, enterprise value near 3.4 B, and a workforce of about 1,849 people.Profitability
Profitability analysis for Alignment Healthcare LLC should focus on how efficiently revenue converts into operating income, net income, and ultimately free cash flow that can be reinvested or returned to shareholders. Annual revenue is about 3.95 Billion. Investors should compare gross, operating, and net margins rather than relying on one headline figure.
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.03 | 0.03 |
Management Efficiency
The company has return on total asset (ROA) of 1.1 % meaning that it earned $1.1 for every $100 held in assets. This is in the weaker range for the sector. Similarly, it shows a return on stockholder's equity (ROE) of -0.7 %, meaning that it generated a substantial loss on money invested by shareholders.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.91 | 0.58 | |
| Tangible Book Value Per Share | 0.72 | 0.41 | |
| Enterprise Value Over EBITDA | 81.13 | 85.19 | |
| Price Book Value Ratio | 21.81 | 22.44 | |
| Enterprise Value Multiple | 81.13 | 85.19 | |
| Price Fair Value | 21.81 | 22.44 | |
| Enterprise Value | 1.8 B | 2.5 B |
When investors examine management execution at Alignment Healthcare LLC, they are looking for evidence that strategy, financial discipline, and operating results are moving in the same direction. The business currently sits in the Healthcare sector and the Healthcare Plans industry. Current market capitalization is about 3.68 Billion, enterprise value is near 3.4 Billion, and annual revenue is around 3.95 Billion.
Operating Margin | Long Term Debt Total | Three Month Return -11.57 | Short Long Term Debt Total | Three Year Return 168.33856 |
Technical Drivers
As of the 13th of March 2026, Alignment Healthcare reflects a market price of 16.99 per share. Current technical metrics show Mean Deviation of 2.05, risk adjusted performance of -0.04, and Standard Deviation of 2.87. Technical analytics evaluate momentum, liquidity, and volatility relationships. Current statistics are evaluated within a broader sector context.Alignment Healthcare LLC Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Alignment Healthcare LLC price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Insider Trading Activities
Insider trading disclosures for Alignment Healthcare LLC offer a structured way to watch how people closest to the business are behaving while expectations change across the market. Current market capitalization is about 3.68 Billion. Used properly, these records are better for context than for blind buy-or-sell signals.
Outstanding Bonds
Reviewing Alignment Healthcare LLC bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.
| ATDBCN 355 26 JUL 27 Corp BondUS01626PAH91 | View | |
| ATDBCN 295 25 JAN 30 Corp BondUS01626PAM86 | View | |
| ATDBCN 38 25 JAN 50 Corp BondUS01626PAN69 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Predictive Daily Indicators
Daily trading signals in Alignment Healthcare LLC help active traders monitor momentum, reversals, and volume pressure while the session is still developing. The better setups usually come from combining these signals with strict risk limits, because short-term data can reverse quickly when liquidity thins.
Corporate Filings
F4 | 12th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 10th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 4th of March 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 3rd of March 2026 Other Reports | ViewVerify | |
ASR | 2nd of March 2026 Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
10K | 27th of February 2026 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 26th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 23rd of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Forecast Models
Quantitative forecast tools for Alignment Healthcare LLC focus on patterns in observed data, which makes them especially useful when the market is moving faster than traditional bottom-up research can refresh. Used well, forecast models can complement fundamental research by showing where observed price behavior still supports or contradicts the discretionary thesis.Financial Strength and Earnings Quality Indicators
Alignment Healthcare LLC financial ratings play a critical role in determining how much Alignment Healthcare have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Alignment Healthcare's borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | -2.79 | Unlikely Manipulator | View |
Debt to Cash Allocation
The debt-to-cash mix for Alignment Healthcare helps explain how management balances flexibility and funding cost through a business cycle.
Alignment Healthcare LLC currently holds $338.07 M in liabilities with Debt to Equity (D/E) ratio of 0.61, which is broadly in line with comparable companies. Alignment Healthcare LLC has a current ratio of 3.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Alignment Healthcare's use of debt, we should always consider it together with its cash and equity.Total Assets Over Time
Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Alignment Healthcare uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Alignment Healthcare Debt Ratio | 43.0 |
Corporate Bonds Issued
Bond maturity for Alignment Healthcare is a core risk dimension. Longer duration can offer higher yield, but price sensitivity and credit uncertainty also increase.
Alignment Short Long Term Debt Total
Short Long Term Debt Total | 228.28 Million |
Stock Analysis Methodology
Alignment Healthcare analysis scores fundamental and technical indicators to identify financial strengths and potential vulnerabilities. Alignment Healthcare trades at P/B of 20.52, P/S of 0.93. Profitability metrics show ROE of -0.7%, net margin of -0.02%, operating margin of -1.09%. Balance sheet indicators include debt-to-equity of 0.61 and current ratio of 3.1. Financial distress probability is estimated at 24%, indicating low near-term solvency risk. Beta of 1.3364 suggests moderate market correlation. A negative Sharpe ratio of -0.0801 indicates returns below the risk-free rate over the measurement period. Alignment Healthcare has a market cap of 3.68 B, ROE of -0.7%.
Reported values for Alignment Healthcare LLC are derived from periodic company reporting and market reference feeds and then standardized by Macroaxis analytics. Analyst inputs may be included when coverage is available. Refresh times depend on source availability.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardCurrent Alignment Analyst Rating Consensus
| Target Price | Consensus | # of Analysts | |
| 25.5 | Strong Buy | 11 | Odds |
Alignment Healthcare LLC current and past analyst recommendations are summarized from multiple research sources. Consensus averages are included alongside the recommendation view. Professional analyst coverage of Alignment Healthcare LLC provides individual investors with access to institutional-quality research. Alignment's consensus rating summarizes the prevailing view across all covering analysts, while individual target prices reveal the range of valuation opinions.
Alignment Stock Analysis Indicators
Diagnostics snapshot includes 18 indicators such as Begin Period Cash Flow, Long Term Debt, Common Stock Shares Outstanding.
| Begin Period Cash Flow | 434.9 M | |
| Long Term Debt | 323.2 M | |
| Common Stock Shares Outstanding | 198 M | |
| Total Stockholder Equity | 179.3 M | |
| Total Cashflows From Investing Activities | -15 M | |
| Tax Provision | 20 K | |
| Property Plant And Equipment Net | 71.3 M | |
| Cash And Short Term Investments | 577.9 M | |
| Cash | 577.9 M | |
| Accounts Payable | 474.6 M | |
| Net Debt | -239.9 M | |
| 50 Day M A | 20.7863 | |
| Total Current Liabilities | 476.5 M | |
| Other Operating Expenses | 3.9 B | |
| Non Current Assets Total | 234.6 M | |
| Forward Price Earnings | 208.3333 | |
| Non Currrent Assets Other | 98.3 M | |
| Stock Based Compensation | 62.1 M |
Popular Tools for Alignment Stock analysis
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |